Met Life Investment Management, LLC Ampio Pharmaceuticals, Inc. Transaction History

Met Life Investment Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$0.56 - $1.71 $17,332 - $52,924	-30,950 Closed	0 $0
Q3 2021 May 17, 2024	SELL	$1.21 - $1.8 $58,446 - $86,945	-48,303 Reduced 60.95%	30,950 $51,000
Q3 2021 Jun 21, 2023	BUY	$1.21 - $1.8 $37,449 - $55,710	30,950 New	30,950 $51,000
Q3 2021 Mar 22, 2023	SELL	$1.21 - $1.8 $58,446 - $86,945	-48,303 Reduced 60.95%	30,950 $51,000
Q3 2021 Nov 15, 2021	SELL	$1.21 - $1.8 $58,446 - $86,945	-48,303 Reduced 60.95%	30,950 $51,000
Q2 2021 May 17, 2024	BUY	$1.56 - $1.98 $123,634 - $156,920	79,253 New	79,253 $132,000
Q2 2021 Jun 21, 2023	BUY	$1.56 - $1.98 $123,634 - $156,920	79,253 New	79,253 $132,000
Q2 2021 Mar 22, 2023	BUY	$1.56 - $1.98 $123,634 - $156,920	79,253 New	79,253 $132,000
Q2 2021 Aug 16, 2021	BUY	$1.56 - $1.98 $123,634 - $156,920	79,253 New	79,253 $132,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Market Cap $2.26M
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Met Life Investment Management, LLC with notifications on news.